MINAPHARM Pharmaceuticals reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was EGP 754.82 million compared to EGP 590.79 million a year ago. Net income was EGP 102.01 million compared to EGP 77.64 million a year ago. Basic earnings per share from continuing operations was EGP 8.4 compared to EGP 6.47 a year ago. For the nine months, sales was EGP 2,208.9 million compared to EGP 1,651.79 million a year ago. Net income was EGP 352.37 million compared to EGP 201.13 million a year ago. Basic earnings per share from continuing operations was EGP 29.19 compared to EGP 17.05 a year ago.